BIOVECTRA partners on Canadian solution to establish a domestic supply chain for immunotherapies
BIOVECTRA is pleased to be part of a Canadian solution with NGEN partners CCRM, Precision Nanosytems (Cytiva), Northern RNA, and OmniaBio to establish a Canadian supply chain network to accelerate and standardize lentiviral vector development from clinical to commercial manufacturing.